{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:14:34Z","timestamp":1786994074598,"version":"build-2736575974"},"reference-count":60,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.medcli.2017.12.021","type":"journal-article","created":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T01:27:27Z","timestamp":1520558847000},"page":"242-249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Colangitis biliar primaria"],"prefix":"10.1016","volume":"151","author":[{"given":"Albert","family":"Par\u00e9s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2017.12.021_bib0305","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1089-3261(03)00100-4","article-title":"Natural history of primary biliary cirrhosis","volume":"7","author":"Pares","year":"2003","journal-title":"Clin Liver Dis."},{"key":"10.1016\/j.medcli.2017.12.021_bib0310","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(15)00154-3","article-title":"Primary biliary cirrhosis","volume":"386","author":"Carey","year":"2015","journal-title":"Lancet."},{"key":"10.1016\/j.medcli.2017.12.021_bib0315","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1053\/j.gastro.2015.08.031","article-title":"Changing nomenclature for PBC: From \u2018cirrhosis\u2019 to \u2018cholangitis\u2019","volume":"149","author":"Beuers","year":"2015","journal-title":"Gastroenterology."},{"key":"10.1016\/j.medcli.2017.12.021_bib0320","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic review","volume":"56","author":"Boonstra","year":"2012","journal-title":"J Hepatol."},{"key":"10.1016\/j.medcli.2017.12.021_bib0325","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/hep.21076","article-title":"Increased prevalence of primary biliary cirrhosis near superfund toxic waste sites","volume":"43","author":"Ala","year":"2006","journal-title":"Hepatology."},{"key":"10.1016\/j.medcli.2017.12.021_bib0330","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/aje\/kwt308","article-title":"No rise in incidence but geographical heterogeneity in the occurrence of primary biliary cirrhosis in North East England","volume":"179","author":"McNally","year":"2014","journal-title":"Am J Epidemiol."},{"key":"10.1016\/j.medcli.2017.12.021_bib0335","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1002\/ibd.22938","article-title":"Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease","volume":"18","author":"Boonstra","year":"2012","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.medcli.2017.12.021_bib0340","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.20907","article-title":"Risk factors and comorbidities in primary biliary cirrhosis: A controlled interview-based study of 1032 patients","volume":"42","author":"Gershwin","year":"2005","journal-title":"Hepatology."},{"key":"10.1016\/j.medcli.2017.12.021_bib0345","first-page":"1615","article-title":"Pathogenesis of primary biliary cirrhosis","volume":"56","author":"Jones","year":"2007","journal-title":"Gut."},{"key":"10.1016\/j.medcli.2017.12.021_bib0350","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1399-0039.1979.tb00874.x","article-title":"Primary biliary cirrhosis associated with HLA-DRw3","volume":"14","author":"Ercilla","year":"1979","journal-title":"Tissue Antigens."},{"key":"10.1016\/j.medcli.2017.12.021_bib0355","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1002\/hep.22567","article-title":"Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: A multicenter study of 664 patients and 1992 healthy controls","volume":"48","author":"Invernizzi","year":"2008","journal-title":"Hepatology."},{"key":"10.1016\/j.medcli.2017.12.021_bib0360","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1056\/NEJMoa0810440","article-title":"Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants","volume":"360","author":"Hirschfield","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2017.12.021_bib0365","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/ng.627","article-title":"Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis","volume":"42","author":"Liu","year":"2010","journal-title":"Nat Genet."},{"key":"10.1016\/j.medcli.2017.12.021_bib0370","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/S0140-6736(10)61965-4","article-title":"Primary biliary cirrhosis","volume":"377","author":"Selmi","year":"2011","journal-title":"Lancet."},{"key":"10.1016\/j.medcli.2017.12.021_bib0375","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/hep.1840100402","article-title":"Frequency of IgG and IgM autoantibodies to four specific M2 mitochondrial autoantigens in primary biliary cirrhosis","volume":"10","author":"Mutimer","year":"1989","journal-title":"Hepatology."},{"key":"10.1016\/j.medcli.2017.12.021_bib0380","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0168-8278(94)80117-7","article-title":"Cross-reactivity of anti-Mycobacterium gordonae antibodies with the major mitochondrial autoantigens in primary biliary cirrhosis","volume":"21","author":"Vilagut","year":"1994","journal-title":"J Hepatol."},{"key":"10.1016\/j.medcli.2017.12.021_bib0385","doi-asserted-by":"crossref","first-page":"8454","DOI":"10.1073\/pnas.1433063100","article-title":"Does a \u03b2retrovirus infection trigger primary biliary cirrhosis?","volume":"100","author":"Xu","year":"2003","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1016\/j.medcli.2017.12.021_bib0390","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1053\/j.gastro.2003.09.034","article-title":"Autoreactivity to lipoate and a conjugated form of lipoate in primary biliary cirrhosis","volume":"125","author":"Bruggraber","year":"2003","journal-title":"Gastroenterology."},{"key":"10.1016\/j.medcli.2017.12.021_bib0395","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1055\/s-0036-1597929","article-title":"novel treatment strategies for primary biliary cholangitis","volume":"37","author":"Pares","year":"2017","journal-title":"Semin Liver Dis."},{"key":"10.1016\/j.medcli.2017.12.021_bib0400","first-page":"387","article-title":"Primary biliary cirrhosis. Chronic non-suppurative destructive cholangitis","volume":"46","author":"Rubin","year":"1965","journal-title":"Am J Pathol"},{"key":"10.1016\/j.medcli.2017.12.021_bib0405","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/gut.49.2.276","article-title":"Dutch multicentre PBC study group. Jaundice in non-cirrhotic primary biliary cirrhosis: The premature ductopenic variant","volume":"49","author":"Vleggaar","year":"2001","journal-title":"Gut."},{"key":"10.1016\/j.medcli.2017.12.021_bib0410","first-page":"1257","article-title":"Primary biliary cirrhosis","volume":"60","author":"Scheuer","year":"1967","journal-title":"Proc R Soc Med."},{"key":"10.1016\/j.medcli.2017.12.021_bib0415","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00432479","article-title":"Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)","volume":"379","author":"Ludwig","year":"1978","journal-title":"Virchows Arch A Pathol Anat Histol."},{"key":"10.1016\/j.medcli.2017.12.021_bib0420","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0016-5085(92)90771-P","article-title":"Nodular regenerative hyperplasia of the liver in early histological stages of primary biliary cirrhosis","volume":"102","author":"Colina","year":"1992","journal-title":"Gastroenterology."},{"key":"10.1016\/j.medcli.2017.12.021_bib0425","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"Clinical practice guidelines: Management of cholestatic liver diseases","volume":"51","year":"2009","journal-title":"J Hepatol."},{"key":"10.1016\/j.medcli.2017.12.021_bib0430","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/hep.26909","article-title":"Pruritus in cholestasis: Facts and fiction","volume":"60","author":"Beuers","year":"2014","journal-title":"Hepatology."},{"key":"10.1016\/j.medcli.2017.12.021_bib0435","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0168-8278(87)80035-1","article-title":"Portal hypertension in primary biliary cirrhosis. Relationship with histological features","volume":"5","author":"Navasa","year":"1987","journal-title":"J Hepatol."},{"key":"10.1016\/j.medcli.2017.12.021_bib0440","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.cld.2008.02.005","article-title":"Osteoporosis in primary biliary cirrhosis: Pathogenesis and treatment","author":"Pares","year":"2008","journal-title":"Clin Liver Dis."},{"key":"10.1016\/j.medcli.2017.12.021_bib0445","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jhep.2004.11.035","article-title":"Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis","volume":"42","author":"Guanabens","year":"2005","journal-title":"J Hepatol."},{"key":"10.1016\/j.medcli.2017.12.021_bib0450","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/hep.23095","article-title":"Incidence, risk factors, and survival of hepatocellular carcinoma in primary biliary cirrhosis: Comparative analysis from two centers","volume":"50","author":"Cavazza","year":"2009","journal-title":"Hepatology."},{"key":"10.1016\/j.medcli.2017.12.021_bib0455","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/gutjnl-2014-308351","article-title":"Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: A multicentre international study","volume":"65","author":"Trivedi","year":"2016","journal-title":"Gut."},{"key":"10.1016\/j.medcli.2017.12.021_bib0460","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s12016-014-8446-7","article-title":"Extrahepatic malignancies in primary biliary cirrhosis: A comparative study at two European centers","volume":"48","author":"Floreani","year":"2015","journal-title":"Clin Rev Allergy Immunol."},{"key":"10.1016\/j.medcli.2017.12.021_bib0465","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/gut.2003.036558","article-title":"Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis","volume":"54","author":"Rigopoulou","year":"2005","journal-title":"Gut."},{"key":"10.1016\/j.medcli.2017.12.021_bib0470","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/hep.1840080438","article-title":"Autoantibodies against nuclear envelope-associated proteins in primary biliary cirrhosis","volume":"8","author":"Lozano","year":"1988","journal-title":"Hepatology."},{"key":"10.1016\/j.medcli.2017.12.021_bib0475","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/liv.12690","article-title":"Anti-kelch-like 12 and anti-hexokinase 1: Novel autoantibodies in primary biliary cirrhosis","volume":"35","author":"Norman","year":"2015","journal-title":"Liver Int."},{"key":"10.1016\/j.medcli.2017.12.021_bib0480","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology."},{"key":"10.1016\/j.medcli.2017.12.021_bib0485","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","article-title":"Overlap syndromes: The International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue","volume":"54","author":"Boberg","year":"2011","journal-title":"J Hepatol."},{"key":"10.1016\/j.medcli.2017.12.021_bib0490","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/hep.25599","article-title":"Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis","volume":"56","author":"Corpechot","year":"2012","journal-title":"Hepatology."},{"key":"10.1016\/j.medcli.2017.12.021_bib0495","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1053\/j.gastro.2012.12.005","article-title":"Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid","author":"Carbone","year":"2013","journal-title":"Gastroenterology."},{"key":"10.1016\/j.medcli.2017.12.021_bib0500","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","article-title":"Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid","volume":"130","author":"Pares","year":"2006","journal-title":"Gastroenterology."},{"key":"10.1016\/j.medcli.2017.12.021_bib0505","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1053\/j.gastro.2014.08.029","article-title":"Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: An international follow-up study","volume":"147","author":"Lammers","year":"2014","journal-title":"Gastroenterology."},{"key":"10.1016\/j.medcli.2017.12.021_bib0510","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1053\/j.gastro.2015.07.061","article-title":"Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy","volume":"149","author":"Lammers","year":"2015","journal-title":"Gastroenterology."},{"key":"10.1016\/j.medcli.2017.12.021_bib0515","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/hep.28017","article-title":"The UK-PBC risk scores: Derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis","volume":"63","author":"Carbone","year":"2016","journal-title":"Hepatology."},{"key":"10.1016\/j.medcli.2017.12.021_bib0520","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jhep.2014.01.029","article-title":"Optimising risk stratification in primary biliary cirrhosis: AST\/platelet ratio index predicts outcome independent of ursodeoxycholic acid response","volume":"60","author":"Trivedi","year":"2014","journal-title":"J Hepatol."},{"key":"10.1016\/j.medcli.2017.12.021_bib0525","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1055\/s-0034-1383733","article-title":"Old and novel therapies for primary biliary cirrhosis","volume":"34","author":"Pares","year":"2014","journal-title":"Semin Liver Dis."},{"key":"10.1016\/j.medcli.2017.12.021_bib0530","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0168-8278(00)80216-0","article-title":"Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: Results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver","volume":"32","author":"Pares","year":"2000","journal-title":"J Hepatol."},{"key":"10.1016\/j.medcli.2017.12.021_bib0535","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.22428","article-title":"Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis","volume":"48","author":"Corpechot","year":"2008","journal-title":"Hepatology."},{"key":"10.1016\/j.medcli.2017.12.021_bib0540","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1053\/j.gastro.2009.01.003","article-title":"Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid","volume":"136","author":"Kuiper","year":"2009","journal-title":"Gastroenterology."},{"key":"10.1016\/j.medcli.2017.12.021_bib0545","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/ajg.2010.216","article-title":"Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis","volume":"105","author":"Kumagi","year":"2010","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.medcli.2017.12.021_bib0550","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.jhep.2011.02.031","article-title":"Early primary biliary cirrhosis: Biochemical response to treatment and prediction of long-term outcome","volume":"55","author":"Corpechot","year":"2011","journal-title":"J Hepatol."},{"key":"10.1016\/j.medcli.2017.12.021_bib0555","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/hep.26322","article-title":"Early biochemical response to ursodeoxycholic acid and long-term prognosis of primary biliary cirrhosis: Results of a 14-year cohort study","volume":"58","author":"Zhang","year":"2013","journal-title":"Hepatology."},{"key":"10.1016\/j.medcli.2017.12.021_bib0560","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1053\/j.gastro.2014.12.005","article-title":"Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid","volume":"148","author":"Hirschfield","year":"2015","journal-title":"Gastroenterology."},{"key":"10.1016\/j.medcli.2017.12.021_bib0565","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A placebo-controlled trial of obeticholic acid in primary biliary cholangitis","volume":"375","author":"Nevens","year":"2016","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medcli.2017.12.021_bib0570","article-title":"A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis","author":"Kowdley","year":"2017","journal-title":"Hepatology."},{"key":"10.1016\/j.medcli.2017.12.021_bib0575","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/liv.12290","article-title":"Bezafibrate normalizes alkaline phosphatase in primary biliary cirrhosis patients with incomplete response to ursodeoxycholic acid","volume":"34","author":"Lens","year":"2014","journal-title":"Liver Int."},{"key":"10.1016\/j.medcli.2017.12.021_bib0580","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/ajg.2017.287","article-title":"Effects of bezafibrate on outcome and pruritus in primary biliary cholangitis with suboptimal ursodeoxycholic acid response","volume":"113","author":"Reig","year":"2018","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.medcli.2017.12.021_bib0585","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0140-6736(89)91608-5","article-title":"Comparison of rifampicin with phenobarbitone for treatment of pruritus in biliary cirrhosis","volume":"1","author":"Bachs","year":"1989","journal-title":"Lancet."},{"key":"10.1016\/j.medcli.2017.12.021_bib0590","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/0016-5085(92)90335-V","article-title":"Effects of long-term rifampicin administration in primary biliary cirrhosis","volume":"102","author":"Bachs","year":"1992","journal-title":"Gastroenterology."},{"key":"10.1016\/j.medcli.2017.12.021_bib0595","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/hep.21553","article-title":"Sertraline as a first-line treatment for cholestatic pruritus","volume":"45","author":"Mayo","year":"2007","journal-title":"Hepatology."},{"key":"10.1016\/j.medcli.2017.12.021_bib0600","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jhep.2010.02.031","article-title":"Treatment of resistant pruritus from cholestasis with albumin dialysis: Combined analysis of patients from three centers","volume":"53","author":"Pares","year":"2010","journal-title":"J Hepatol."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775318300836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775318300836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T13:01:12Z","timestamp":1536670872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775318300836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0025775318300836"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2017.12.021","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Colangitis biliar primaria","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2017.12.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}